These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33565017)

  • 1. Healing of intrabony defects following regenerative surgery by means of single-flap approach in conjunction with either hyaluronic acid or an enamel matrix derivative: a 24-month randomized controlled clinical trial.
    Pilloni A; Rojas MA; Marini L; Russo P; Shirakata Y; Sculean A; Iacono R
    Clin Oral Investig; 2021 Aug; 25(8):5095-5107. PubMed ID: 33565017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.
    Windisch P; Iorio-Siciliano V; Palkovics D; Ramaglia L; Blasi A; Sculean A
    Clin Oral Investig; 2022 Feb; 26(2):1811-1821. PubMed ID: 34491446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
    Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
    J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.
    Moreno Rodríguez JA; Ortiz Ruiz AJ
    Clin Oral Investig; 2022 Mar; 26(3):2793-2805. PubMed ID: 34791548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
    Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
    Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
    Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
    J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Berakdar M; Donos N; Auschill TM; Arweiler NB
    Clin Oral Investig; 2003 Jun; 7(2):108-12. PubMed ID: 12720115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
    Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
    J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of periodontal suprabony defects following treatment with open flap debridement with or without an enamel matrix derivative: A randomized controlled clinical study.
    Iorio-Siciliano V; Blasi A; Stratul SI; Ramaglia L; Octavia V; Salvi GE; Sculean A
    Clin Oral Investig; 2021 Mar; 25(3):1019-1027. PubMed ID: 32562077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Radiographic Evaluation of Intrabony Periodontal Defects Treated with Hyaluronic Acid or Enamel Matrix Proteins: A 6-Month Prospective Study.
    Vela OC; Boariu M; Rusu D; Iorio-Siciliano V; Sculean A; Stratul SI
    Oral Health Prev Dent; 2024 Jul; 22():257-270. PubMed ID: 38994786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: randomized controlled clinical trial.
    Mamajiwala AS; Sethi KS; Raut CP; Karde PA; Mamajiwala BS
    Clin Oral Investig; 2021 Sep; 25(9):5257-5271. PubMed ID: 33598778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G; Wennström JL
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of the entire papilla preservation technique with and without biomaterials in the treatment of isolated intrabony defects: A randomized controlled clinical trial.
    Aslan S; Buduneli N; Cortellini P
    J Clin Periodontol; 2020 Apr; 47(4):470-478. PubMed ID: 31925811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.
    Cimões R; Santiago LM; de França Caldas Júnior A; de Carvalho Farias Vajgel B; Perussolo J; Donos N
    Clin Oral Investig; 2022 Mar; 26(3):2479-2489. PubMed ID: 34643808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.